Study
The cell free DNA methylome of primary and metastatic prostate tumors
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001005522 | Other |
Study Description
Study Datasets 5 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001007972 |
We analyzed the cell free DNA methylomes using 30 plasma samples from patients with localized prostate cancer in the CPC-GENE project. Methylation was profiled using the methylated DNA immunoprecipitation coupled to next generation sequencing (MeDIP) technology.
|
HiSeq X Ten | 30 |
| EGAD00001008711 |
We analyzed the cell free DNA methylomes using 67 plasma samples from patients with mCRPC prostate cancer in the VPC project. Methylation was profiled using the methylated DNA immunoprecipitation coupled to next generation sequencing (MeDIP) technology.
|
HiSeq X Ten | 62 |
| EGAD00001008712 |
We analyzed the cell free DNA methylomes using 14 plasma samples from patients with mCRPC in the Barrier cohort. Methylation was profiled using the methylated DNA immunoprecipitation coupled to next generation sequencing (MeDIP) technology.
|
HiSeq X Ten | 14 |
| EGAD00001008713 |
We analyzed the cell free DNA methylomes using 22 plasma samples from patients with mCRPC prostate cancer in the WCDT project. Methylation was profiled using the methylated DNA immunoprecipitation coupled to next generation sequencing (MeDIP) technology.
|
HiSeq X Ten | 22 |
| EGAD00001008737 |
We analyzed the cell free DNA methylomes using 72 plasma samples from patients with mCRPC prostate cancer in the VPC project for validation. Methylation was profiled using the methylated DNA immunoprecipitation coupled to next generation sequencing (MeDIP) technology. Files from multiple lanes exists per sample.
|
HiSeq X Ten | 72 |
Who archives the data?
Publications
Citations
Retrieving...
Retrieving...
